BioLineRx, a biopharmaceutical development company, announced today it has signed a worldwide, exclusive license agreement with Genoscience and RFS Pharma to develop and commercialize BL-8030, an orally available treatment for Hepatitis C.

MannKind Corporation today announced that it has entered into a purchase agreement with The Mann Group LLC, an entity controlled by MannKind's chief executive officer and principal stockholder, Alfred E. Mann, for the sale of shares of its common stock to The Mann Group.

Impax Pharmaceuticals, the branded products business unit of Impax Laboratories, Inc., announced today that it has licensed from AstraZeneca the exclusive United States (U.S.) commercial rights to Zomig (zolmitriptan) tablet, orally disintegrating tablet, and nasal spray formulations.

Horizon Software International, the leader in K-12 food service technology and online account management, has been awarded a three-year national group purchasing contract with the Premier healthcare alliance.

Columbia University and Health Fidelity, Inc. announced today that they have entered into a license agreement for commercialization of Columbia's MedLEE Natural Language Processing technology.

Shire plc, the global specialty biopharmaceutical company, announced today that it has acquired the rights to develop and market Resolor (prucalopride) in the United States (US) in an agreement with Janssen Pharmaceutica N.V.

Boulder Diagnostics Inc. and the Department of Internal Medicine, Radboud University Nijmegen Medical Centre announced today the entry into a license and collaboration agreement to market the innovative Lyme disease diagnostic test developed at RUNMC.

Regeneron Pharmaceuticals, Inc. today announced that the Company has entered into a non-exclusive license and partial settlement agreement with Genentech, Inc., a member of the Roche Group relating to U.S. ophthalmic sales of EYLEA (aflibercept) Injection.

Humans pump thousands of tons of vapor from the metallic element mercury into the atmosphere each year, and it can remain suspended for long periods before being changed into a form that is easily removed from the atmosphere. New research shows that the upper troposphere and lower stratosphere work to ...

Humans pump thousands of tons of vapor from the metallic element mercury into the atmosphere each year, and it can remain suspended for long periods before being changed into a form that is easily removed from the atmosphere. New research shows that the upper troposphere and lower ...

SomaLogic, Inc. and AmberGen, Inc. announced today that they have entered into a licensing agreement whereby AmberGen will provide its proprietary photocleavable biotin reagent for the commercial use of SomaLogic's SOMAscan technology platform.

Exelixis, Inc. today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute's Cancer Therapy Evaluation Program (CTEP) for further evaluation of cabozantinib, Exelixis' lead compound, in a variety of solid tumors.